InsidersTradesSigma
Discover the detailed record of transactions filed by Floyd Eric, 董事. Officer active across 1 company, notably Virpax Pharmaceuticals, Inc.. Aggregated, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €6k. History available since 18 May 2022. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Floyd Eric is a Director at Virpax Pharmaceuticals, Inc. He plays a key role in the governance of the company, participating in strategic decisions and ensuring compliance with industry standards. His experience in the pharmaceutical sector is valuable in guiding growth initiatives.